During my medical training in the 1990s, I was taught that insulin was a last resort after patients with Type 2 diabetes had “failed” oral medications, meaning their blood sugar remained worryingly high.
A huge assortment of 100 medications are available to treat high blood sugar in Type 2 diabetes, including two historical breakthrough drugs, insulin and metformin.
Gerald Reaven’s decades of research at Stanford helped show that insulin resistance could lead to Type 2 diabetes and multiple other diseases.
Stanford researchers have found that, contrary to previous studies, insulin levels and a specific genotype pattern don’t predict weight-loss success.
Your voice has been heard! Join us in thanking Congress for passing a renewal of the Special Diabetes Program!
Mary Leonard, chair of the Department of Pediatrics at Stanford, works to understand exactly how chronic diseases hurt children’s bone health.
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.
Diabetes is a disease defined by its complications. High blood sugar contributes to many, but not all, of these potential consequences, so it’s logical that medications to lower blood sugar are central to managing diabetes. But focusing on blood sugar alone does not get the job done.
As a physician, I often consider how to measure success for treating patients with diabetes. Keeping blood sugar lower with the use of medications — a top focus of most doctors — is critical.